BCL9L Antikörper (AA 525-575)
-
- Target Alle BCL9L Antikörper anzeigen
- BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))
-
Bindungsspezifität
- AA 525-575
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BCL9L Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP)
- Verwendungszweck
- Rabbit anti-BCL9L Antibody, Affinity Purified
- Aufreinigung
- Affinity Purified
- Immunogen
- between AA 525 and 575
- Isotyp
- IgG
- Top Product
- Discover our top product BCL9L Primärantikörper
-
-
- Applikationshinweise
-
IP: 2 - 10 μg/mg lysate
WB: 1:2,000 - 1:10,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1000 μg/mL
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))
- Andere Bezeichnung
- BCL9L (BCL9L Produkte)
- Synonyme
- BCL9-2 antikoerper, DLNB11 antikoerper, B9L antikoerper, BC003321 antikoerper, bcl9-2 antikoerper, BCL9L antikoerper, B-cell CLL/lymphoma 9 like antikoerper, B cell CLL/lymphoma 9-like antikoerper, B-cell CLL/lymphoma 9-like antikoerper, BCL9L antikoerper, Bcl9l antikoerper, bcl9l antikoerper
- Hintergrund
- Background: B-cell lymphoma 9-like protein (BCL9L) is a transcriptional regulator that acts as an activator. BCL9L promotes beta-catenin transcriptional activity and plays a role in tumorigenesis [taken from the Universal Protein Resource (UniProt) Q86UU0].
- Gen-ID
- 283149
- NCBI Accession
- NP_872363
- UniProt
- Q86UU0
- Pathways
- Stem Cell Maintenance
-